Board Meeting20 May 2026, 03:59 pm
Medicamen Biotech Board Meeting on May 27, 2026 to Approve Results
AI Summary
Medicamen Biotech Ltd has scheduled a Board of Directors meeting on May 27, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also consider the recommendation of a final dividend on equity shares for the financial year 2025-26, and the appointment of Cost and Internal Auditors for the financial year 2026-27. The trading window has been closed since April 1, 2026, and will open 48 hours after the financial results are declared.
Key Highlights
- Board meeting scheduled for May 27, 2026, to approve audited financial results.
- Consideration of final dividend on equity shares for FY 2025-26.
- Appointment of Cost Auditor for FY 2026-27.
- Appointment of Internal Auditor for FY 2026-27.
- Trading window closed from April 1, 2026, to 48 hours post results declaration.
Price Impact
More from MEDICAMEQ